Stock Code: China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) stock abbreviation: China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) No.: 2022021
China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999)
Announcement of the resolution of the second extraordinary general meeting of shareholders in 2022
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions. Important:
1. There is no resolution at this shareholders’ meeting.
2. This general meeting of shareholders does not involve changing the resolutions adopted at the previous general meeting of shareholders.
1、 Convening and attendance of the meeting
1. China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) 2022 the second extraordinary general meeting of shareholders was held by combining on-site voting and online voting. The on-site meeting was held at 14:30 p.m. on March 3, 2022 in conference room 105 of the company’s comprehensive office center. At the same time, the voting time of the general meeting of shareholders through the trading system of Shenzhen stock exchange is 9:15-9:25, 9:30-11:30 and 13:00-15:00 on March 3, 2022; The time of voting through the Internet voting system of Shenzhen stock exchange is any time from 9:15 to 15:00 on March 3, 2022.
2. The shareholders attending the general meeting are as follows:
Number of shareholders attending the meeting and authorized representatives of shareholders 14
Number of representative shares (shares) 685900485
Proportion in total voting shares of the company (%) 700685
among
1. Number of shareholders attending the on-site meeting and authorized representatives of shareholders 6
Number of representative shares (shares) 633094982
Proportion in total voting shares of the company (%) 646741
2. Number of shareholders participating in online voting and authorized representatives of shareholders 8
Number of representative shares (shares) 52805503
Proportion in total voting shares of the company (%) 5.3944
3. Minority shareholders participating in voting (except directors, supervisors and senior managers of the company)
And shares other than shareholders who individually or jointly hold more than 5% of the shares of the company 13
(East) and number of authorized representatives of shareholders
Number of representative shares (shares) 63330853
Proportion in total voting shares of the company (%) 6.4696
3. The general meeting of shareholders was convened by the board of directors of the company and presided over by the chairman, Mr. Qiu Huawei. Some directors, supervisors, senior managers and witness lawyers of the company attended the meeting.
4. The convening of this general meeting of shareholders complies with the provisions of the company law, the rules for the general meeting of shareholders of listed companies, the Listing Rules of Shenzhen Stock Exchange, the articles of association and other laws, regulations and normative documents.
2、 Consideration and voting of proposals
(I) voting method: on-site written voting and online voting
(II) voting results
1. Proposal on the company’s 2021 restricted stock incentive plan (Revised Draft) and its summary
Overall voting: 652628853 shares were approved, accounting for 951492% of the total number of valid voting shares attending the general meeting of shareholders; 33199187 shares opposed, accounting for 4.8402% of the total number of valid voting shares attending the general meeting of shareholders; 72445 shares were abstained, accounting for 0.0106% of the total number of valid voting shares attending the general meeting of shareholders.
Among them, the voting of minority shareholders (other than directors, supervisors, senior managers and shareholders who individually or jointly hold more than 5% of the company’s shares): Hunan Huakai Cultural And Creative Co.Ltd(300592) 21 shares were agreed, accounting for 474638% of the shares held by minority shareholders attending the meeting; 33199187 shares were opposed, accounting for 524218% of the shares held by minority shareholders attending the meeting; 72445 shares were abstained, accounting for 0.1144% of the shares held by minority shareholders attending the meeting.
Voting results: the proposal is a special resolution proposal, which has been adopted by more than 2 / 3 of the total number of effective voting shares.
2. Proposal on the management measures for the implementation and assessment of the company’s restricted stock incentive in 2021
Overall voting: 652912753 shares were approved, accounting for 951906% of the total number of valid voting shares attending the general meeting of shareholders; 32915287 opposed shares, accounting for 4.7988% of the total number of valid voting shares attending the general meeting of shareholders; 72445 shares were abstained, accounting for 0.0106% of the total number of valid voting shares attending the general meeting of shareholders.
Among them, the voting of minority shareholders (other than directors, supervisors, senior managers and shareholders who individually or jointly hold more than 5% of the company’s shares): 30343121 shares were agreed, accounting for 479121% of the shares held by minority shareholders attending the meeting; 32915287 shares opposed, accounting for 519735% of the shares held by minority shareholders attending the meeting; 72445 shares were abstained, accounting for 0.1144% of the shares held by minority shareholders attending the meeting.
Voting results: the proposal is a special resolution proposal, which has been adopted by more than 2 / 3 of the total number of effective voting shares.
3. The general voting on the proposal of requesting the general meeting of shareholders of the company to authorize the board of directors to handle matters related to the restricted stock incentive plan in 2021: 652855353 shares were approved, accounting for 951822% of the total number of valid voting shares attending the general meeting of shareholders; 32972687 shares opposed, accounting for 4.8072% of the total number of valid voting shares attending the general meeting of shareholders; 72445 shares were abstained, accounting for 0.0106% of the total number of valid voting shares attending the general meeting of shareholders.
Among them, the voting situation of minority shareholders (except directors, supervisors, senior managers and shareholders who individually or jointly hold more than 5% of the shares of the company): 30285721 shares were agreed, accounting for 478214% of the shares held by minority shareholders attending the meeting; Against 32972687 shares, accounting for 520642% of the shares held by minority shareholders attending the meeting; 72445 shares were abstained, accounting for 0.1144% of the shares held by minority shareholders attending the meeting.
Voting results: the proposal is a special resolution proposal, which has been adopted by more than 2 / 3 of the total number of effective voting shares.
4. Proposal on adopting cumulative voting system to elect non independent directors of the eighth board of directors of the company
(1) Elect Mr. Bai Xiaosong as a non independent director of the eighth board of directors of the company
The cumulative voting system was adopted at the meeting, with 681799886 affirmative votes, accounting for 994022% of the voting shares attending the meeting. Mr. Bai Xiaosong was elected as a non independent director of the eighth board of directors of the company.
Among them, the voting situation of minority shareholders (except directors, supervisors, senior managers and other shareholders who individually or jointly hold more than 5% of the shares of the company): 59230254 affirmative votes, accounting for 935251% of the voting shares held by minority shareholders attending the meeting.
(2) Elect Mr. Cui xingpin as a non independent director of the eighth board of directors of the company
The cumulative voting system was adopted at the meeting, with 680364811 affirmative votes, accounting for 991929% of the voting shares attending the meeting. Mr. Cui xingpin was elected as a non independent director of the eighth board of directors of the company.
Among them, the voting situation of minority shareholders (except directors, supervisors, senior managers and other shareholders who individually or jointly hold more than 5% of the shares of the company): 57795179 affirmative votes, accounting for 912591% of the voting shares held by minority shareholders attending the meeting.
(3) Elect Mr. Zhao Bingxiang as a non independent director of the eighth board of directors of the company
The cumulative voting system was adopted at the meeting, with 681929364 affirmative votes, accounting for 994210% of the voting shares attending the meeting. Mr. Zhao Bingxiang was elected as a non independent director of the eighth board of directors of the company.
Among them, the voting situation of minority shareholders (except directors, supervisors, senior managers and other shareholders who individually or jointly hold more than 5% of the shares of the company): 59359732 affirmative votes, accounting for 937296% of the voting shares held by minority shareholders attending the meeting.
3、 Legal opinions issued by lawyers
Lawyer Li Fang and lawyer yuan Tianyi of Shanghai jintiancheng (Shenzhen) law firm attended the shareholders’ meeting and issued a legal opinion. They believed that the convening and convening procedures, the qualification of attendees, the qualification of conveners, the voting procedures and voting results of the meeting were in line with the company law, the rules of the shareholders’ meeting of listed companies and other laws The relevant provisions of laws, regulations, other normative documents and the articles of association are legal and valid. 4、 Directory of documents for future reference
1. China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) 2022 resolution of the second extraordinary general meeting of shareholders 2. The legal opinion issued by the lawyer is hereby announced.
China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) board of directors
March 3, 2002
